1. Home
  2. STOK vs WNC Comparison

STOK vs WNC Comparison

Compare STOK & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • WNC
  • Stock Information
  • Founded
  • STOK 2014
  • WNC 1985
  • Country
  • STOK United States
  • WNC United States
  • Employees
  • STOK N/A
  • WNC N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • STOK Health Care
  • WNC Industrials
  • Exchange
  • STOK Nasdaq
  • WNC Nasdaq
  • Market Cap
  • STOK 517.0M
  • WNC 425.6M
  • IPO Year
  • STOK 2019
  • WNC 1991
  • Fundamental
  • Price
  • STOK $9.36
  • WNC $8.72
  • Analyst Decision
  • STOK Strong Buy
  • WNC Hold
  • Analyst Count
  • STOK 5
  • WNC 1
  • Target Price
  • STOK $27.50
  • WNC $14.00
  • AVG Volume (30 Days)
  • STOK 813.9K
  • WNC 1.3M
  • Earning Date
  • STOK 05-20-2025
  • WNC 04-30-2025
  • Dividend Yield
  • STOK N/A
  • WNC 3.67%
  • EPS Growth
  • STOK N/A
  • WNC N/A
  • EPS
  • STOK N/A
  • WNC N/A
  • Revenue
  • STOK $36,555,000.00
  • WNC $1,812,354,000.00
  • Revenue This Year
  • STOK $27.80
  • WNC N/A
  • Revenue Next Year
  • STOK $9.53
  • WNC $15.75
  • P/E Ratio
  • STOK N/A
  • WNC N/A
  • Revenue Growth
  • STOK 316.34
  • WNC N/A
  • 52 Week Low
  • STOK $5.35
  • WNC $6.78
  • 52 Week High
  • STOK $17.58
  • WNC $24.03
  • Technical
  • Relative Strength Index (RSI)
  • STOK 57.94
  • WNC 43.95
  • Support Level
  • STOK $8.30
  • WNC $6.78
  • Resistance Level
  • STOK $10.12
  • WNC $8.47
  • Average True Range (ATR)
  • STOK 0.59
  • WNC 0.56
  • MACD
  • STOK -0.03
  • WNC -0.01
  • Stochastic Oscillator
  • STOK 58.24
  • WNC 51.32

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: